FDA Inspection
Chartwell Pharmaceuticals LLCChartwell Pharmaceuticals LLC – FDA Inspection, Sep 26, 2018
Record Details
This FDA Inspection record concerns Chartwell Pharmaceuticals LLC, with an inspection on September 26, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ce599aaf-7679-4329-b697-cd159f9d72e3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1068395
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Chartwell Pharmaceuticals LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2025 | OAI | New York District Office | Drug Quality Assurance |
| December 19, 2024 | Not classified | New York District Office | Drug Quality Assurance |
| May 31, 2024 | OAI | New York District Office | Generic Drug Evaluation |
| April 8, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 24, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chartwell Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.